Malignant Pleural Mesothelioma, Advanced Clinical Trials in Tianjin, Tianjin Municipality

Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural Mesothelioma